Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00604799 · ClinicalTrials.gov registry record · Phase 2
VALOR: The Talent Thoracic Stent Graft System Clinical Study
A Phase 2 study, sponsored by Medtronic Cardiovascular.
- Completed
- Registry status
- Phase 2
- Development phase
- 379
- Enrollment target
NCT00604799 is a Phase 2 study that has completed, run by Medtronic Cardiovascular. The registered enrollment target is 379 participants.
The verdict
NCT00604799, a Phase 2 study, has completed, sponsored by Medtronic Cardiovascular.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 379 participants
- Enrollment target
Study Summary
A Descending Thoracic Aneurysm is a bulge in the aorta. The aorta is a large blood vessel that carries blood away from your heart to organs in the rest of your body. Your aneurysm is caused by a weakening in the artery wall. If left untreated, this bulge may continue to grow larger and may ultimately rupture (break open) or extend in size to seriously affect other major arteries in the area. In this Research Study a device will be placed inside your aorta to block the weakened part of the artery wall from the circulatory system. Information will be collected on the performance for the device for 5 years.
Interventions
- DEVICE Talent Thoracic Stent Graft
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 379 participants |
| Start Date | 2003-07 |
| Est. Completion | 2011-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00604799
The ClinicalTrials.gov registry entry for NCT00604799 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 379 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiovascular, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Talent Thoracic Stent Graft is the first listed.
NCT00604799 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00604799 about?
NCT00604799 is a clinical study titled "VALOR: The Talent Thoracic Stent Graft System Clinical Study". A Descending Thoracic Aneurysm is a bulge in the aorta. The aorta is a large blood vessel that carries blood away from your heart to organs in the rest of your body. Your aneurysm is caused by a weakening in the artery wall. If left untreated, this bulge may continue to grow larger and may ultimatel...
What is the current status of trial NCT00604799?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 379 participants. The study started on 2003-07. Estimated completion is 2011-06.
What interventions are being tested in trial NCT00604799?
The interventions under investigation include: Talent Thoracic Stent Graft (DEVICE).
Who is sponsoring clinical trial NCT00604799?
This trial is sponsored by Medtronic Cardiovascular, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.